These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25559317)

  • 1. Molecular basis of endosomal-membrane association for the dengue virus envelope protein.
    Rogers DM; Kent MS; Rempe SB
    Biochim Biophys Acta; 2015 Apr; 1848(4):1041-52. PubMed ID: 25559317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavivirus cell entry and membrane fusion.
    Smit JM; Moesker B; Rodenhuis-Zybert I; Wilschut J
    Viruses; 2011 Feb; 3(2):160-171. PubMed ID: 22049308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dengue virus ensures its fusion in late endosomes using compartment-specific lipids.
    Zaitseva E; Yang ST; Melikov K; Pourmal S; Chernomordik LV
    PLoS Pathog; 2010 Oct; 6(10):e1001131. PubMed ID: 20949067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Envelope E protein of dengue virus and phospholipid binding to the late endosomal membrane.
    Villalaín J
    Biochim Biophys Acta Biomembr; 2022 May; 1864(5):183889. PubMed ID: 35167815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insertion of Dengue E into lipid bilayers studied by neutron reflectivity and molecular dynamics simulations.
    Vanegas JM; Heinrich F; Rogers DM; Carson BD; La Bauve S; Vernon BC; Akgun B; Satija S; Zheng A; Kielian M; Rempe SB; Kent MS
    Biochim Biophys Acta Biomembr; 2018 May; 1860(5):1216-1230. PubMed ID: 29447917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Aspects of the Dengue Virus Infection Process: A Review.
    Zonetti LFC; Coutinho MC; de Araujo AS
    Protein Pept Lett; 2018; 25(8):712-719. PubMed ID: 29984641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensive structural change of the envelope protein of dengue virus induced by a tuned ionic strength: conformational and energetic analyses.
    Degrève L; Fuzo CA; Caliri A
    J Comput Aided Mol Des; 2012 Dec; 26(12):1311-25. PubMed ID: 23160852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of dengue virus type 1 envelope protein in the postfusion conformation and its implications for membrane fusion.
    Nayak V; Dessau M; Kucera K; Anthony K; Ledizet M; Modis Y
    J Virol; 2009 May; 83(9):4338-44. PubMed ID: 19244332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pushing the Envelope: Dengue Viral Membrane Coaxed into Shape by Molecular Simulations.
    Marzinek JK; Holdbrook DA; Huber RG; Verma C; Bond PJ
    Structure; 2016 Aug; 24(8):1410-1420. PubMed ID: 27396828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the dengue virus envelope protein after membrane fusion.
    Modis Y; Ogata S; Clements D; Harrison SC
    Nature; 2004 Jan; 427(6972):313-9. PubMed ID: 14737159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How small-molecule inhibitors of dengue-virus infection interfere with viral membrane fusion.
    Chao LH; Jang J; Johnson A; Nguyen A; Gray NS; Yang PL; Harrison SC
    Elife; 2018 Jul; 7():. PubMed ID: 29999491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel binding between pre-membrane protein and claudin-1 is required for efficient dengue virus entry.
    Gao F; Duan X; Lu X; Liu Y; Zheng L; Ding Z; Li J
    Biochem Biophys Res Commun; 2010 Jan; 391(1):952-7. PubMed ID: 19962368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promotion of vesicular stomatitis virus fusion by the endosome-specific phospholipid bis(monoacylglycero)phosphate (BMP).
    Roth SL; Whittaker GR
    FEBS Lett; 2011 Mar; 585(6):865-9. PubMed ID: 21333650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
    Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
    Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the interaction of domain III of the envelope protein of dengue virus with putative receptors from CHO cells.
    Huerta V; Chinea G; Fleitas N; Sarría M; Sánchez J; Toledo P; Padrón G
    Virus Res; 2008 Nov; 137(2):225-34. PubMed ID: 18723056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and dynamics of the monomer of protein E of dengue virus type 2 with unprotonated histidine residues.
    Degrève L; Fuzo CA
    Genet Mol Res; 2013 Feb; 12(1):348-59. PubMed ID: 23420360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-Guided De Novo Design of Dengue Envelope Protein Inhibitors.
    Desai VH; Kumar SP; Pandya HA; Solanki HA
    Appl Biochem Biotechnol; 2015 Oct; 177(4):861-78. PubMed ID: 26299376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro reconstitution reveals key intermediate states of trimer formation by the dengue virus membrane fusion protein.
    Liao M; Sánchez-San Martín C; Zheng A; Kielian M
    J Virol; 2010 Jun; 84(11):5730-40. PubMed ID: 20335260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel flavanone derivative inhibits dengue virus fusion and infectivity.
    Srivarangkul P; Yuttithamnon W; Suroengrit A; Pankaew S; Hengphasatporn K; Rungrotmongkol T; Phuwapraisirisan P; Ruxrungtham K; Boonyasuppayakorn S
    Antiviral Res; 2018 Mar; 151():27-38. PubMed ID: 29360474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection.
    Panya A; Sawasdee N; Junking M; Srisawat C; Choowongkomon K; Yenchitsomanus PT
    Chem Biol Drug Des; 2015 Nov; 86(5):1093-104. PubMed ID: 25891143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.